Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;45(3):314-30.
doi: 10.1007/s12016-013-8398-3.

Epigenetics in immune-mediated pulmonary diseases

Yu Liu  1 , Hui Li, Tao Xiao, Qianjin Lu
Affiliations
Review

Epigenetics in immune-mediated pulmonary diseases

Yu Liu et al. Clin Rev Allergy Immunol. 2013 Dec.

Abstract

Immune-mediated pulmonary diseases are a group of diseases that resulted from immune imbalance initiated by allergens or of unknown causes. Inflammatory responses without restrictions cause tissue damage and remodeling, which leads to airway hyperactivity, destruction of alveolar architecture, and a resultant loss of lung function. Epigenetic mechanisms have been demonstrated to be involved in inflammation, autoimmunity, and cancer. Recent studies have identified that epigenetic changes also regulate molecular pathways in immune-mediated lung diseases. Aberrant DNA methylation status, dysregulation of histone modifications, as well as altered microRNAs expression could change transcription activity of genes involved in the development of immune-mediated pulmonary diseases, which contributes to skewed differentiation of T cells and proliferation and activation of myofibroblasts, leading to overproduction of inflammatory cytokines and excessive accumulation of extracellular matrix, respectively. Aside from this, epigenetics also explains how environmental exposure influence on gene transcription without genetic changes. It acts as a mediator of the interaction between environmental factors and genetic factors. Identification of the abnormal epigenetic marks in diseases provides novel biomarkers for prediction and diagnosis and affords novel therapeutic targets for those difficult clinical problems, such as steroid-resistance and rapidly progressing fibrosis. In this review, we summarized the latest experimental and translational epigenetic studies in immune-mediated pulmonary diseases, including asthma, idiopathic pulmonary fibrosis, tuberculosis, sarcoidosis, and silicosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Autoimmun. 2012 Dec;39(4):259-71 - PubMed
    1. J Clin Invest. 2013 Nov;123(11):4836-48 - PubMed
    1. Am J Respir Cell Mol Biol. 2008 Nov;39(5):610-8 - PubMed
    1. J Allergy Clin Immunol. 2012 Dec;130(6):1243-55 - PubMed
    1. Drugs Today (Barc). 1998 Jun;34(6):549-61 - PubMed

LinkOut - more resources